Sabra Health Care REIT share price today

Sabra Health Care REIT, Inc.'s share price was $21.09 at the close on 4 November 2026. It has been rising for 1 week. That is 5.5% above its average price over the last 200 trading days. Over the past 13 weeks it has done better than the S&P 500, and it has stayed ahead for 1 week in a row.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today Sabra Health Care REIT, Inc. is in stage 2. The phase helps read everything below.

In the last 52 weeks it traded between $18 and $22, and at that close it sat 70% of the way up from that low.

Over the last 10 years the share price moved +1% while the S&P 500 moved +261%, so it is behind the index over that whole period. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

Sabra Health Care REIT, Inc. paid $1.20 per share over the last four reported quarters. The most recent declaration was $0.30 for Jun 2026. At today's price of $21.09 that is a yield of 5.69%, based on dividends already paid, not a forecast.

A dividend is cash paid out for each share. The 12-month total is the four most recent quarters added together.

Sabra Health Care REIT is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list.

Sabra Health Care REIT, Inc. posted a net loss of $25.2 M in the Jun 2026 quarter. Full-year FY25 profit was $156 M. That loss is 10.6% of the quarter's revenue. The same quarter a year earlier earned $65.5 M. 2 of the last 12 reported quarters were loss-making.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

Jun 2026 profit was −$25.2 M, −138.5% on a year earlier. For the full year, FY25 profit was $156 M (+22.8% on the year before).

Why profit moved: revenue changed +25.3% on a year earlier and the margin moved −50.9 percentage points. Sales did the work while the margin got thinner.

On average over the last four quarters, profit changed −50.8% and revenue +17.5%. Profit is growing slower than sales: rising costs are taking part of the growth.

Sabra Health Care REIT, Inc. reported $238 M of revenue in the Jun 2026 quarter, +25.3% on the same quarter a year earlier. That is the 12th quarter in a row with growth on the year before. Over 4 years it has grown 18.9% a year on average. The last full year, FY25, came in at $776 M.

Revenue is everything the company billed its customers in the period.

The last four reported quarters add to $864 M.

FY25 revenue was $776 M, +10.4% on the year before.

Recent pace: the last four quarters grew +17.5% on average, against 18.9% a year over the longer run, so this year is growing slower than its own long-run rate.

Is growth speeding up? Revenue over the last 12 months grew +17.7%, against +13.9% a year over the last 8 quarters (accelerating); profit over the last 12 months grew −64.1%, against +11.9% a year (rolling over).

Sabra Health Care REIT, Inc.'s operating margin was −12.5% in the Jun 2026 quarter, 50.9 percentage points lower than the same quarter a year ago. Across 5 years it has been between 7.6% and 36.5%. The latest quarter is below every full year in that period.

Operating margin is what is left from every $100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

Why: the operating margin move is clear, but the cost details behind it are not in our data, so we show the move without guessing the reason.

Over the last 3 years, 324% of Sabra Health Care REIT, Inc.'s reported profit came in as cash from its operations, so the profit is backed by cash. In FY25 it brought in $349 M of operating cash against $156 M of profit.

The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason.

What to look at next: no single use of cash stands out. The next section checks both the cash tied up in daily operations and the spending on assets.

Sabra Health Care REIT, Inc. does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn.

Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

In short: neither the daily cycle nor new spending is soaking up the cash, so the picture is fairly clean.

Sabra Health Care REIT, Inc.'s P/E is 74.9×, in the middle of its own history: higher than 69% of past readings. Its usual P/E (the middle reading) is 48.0×, over 4.3 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.

P/E is the share price divided by a year's profit per share: how many dollars the market pays for each dollar of yearly profit.

Why the multiple is where it is: over the past year earnings per share moved +18.5% while the price moved +11.7%. Earnings did better than the price, which pulled the multiple down within its own range.

Where the price move came from: over 3 years the price moved +15.0% a year; about +74.2% a year came from earnings growth and about −59.2 percentage points from the multiple (the market paying less). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple.

In short: the multiple is high against its own past, so the earnings trend underneath matters more than the multiple.

Sabra Health Care REIT, Inc.'s business is giving mixed signals. There is no clear direction across the growth lines, with ROCE steady at 2.9%; each line tells part of the story. This is based on 12 quarters of 3 measures, with some gaps.

Every business is somewhere on a path of getting better or worse, and this section names where. The last 12 quarters of growth in revenue, profit and earnings per share, plus the return the business earns on its capital, are read as lines. Getting worse: the lines are falling. Turning around: a low point has just formed and the last few quarters are rising from it. Getting better: the rise from the low has lasted. Growing steadily: steady growth with healthy returns. Slowing from a peak: still high, but slowing. When the lines disagree the result is mixed; too little history means no reading. CAGR (compound annual growth rate) is the steady yearly rate that would turn the starting value into the latest one. It is the fairest way to compare growth over different periods. If the 1-year figure is much bigger than the 10-year one, recent growth is running faster than the long-run trend. A dash means there is no figure for that period, or the starting year was a loss, where a growth rate means nothing.